To date, only one study has reported PALLD germline variants in a woman diagnosed with breast cancer at the age of 38 from a high-risk breast/ovarian cancer Chinese family (a total of 389 patients investigated) [42], but the involvement of this variant in breast cancer risk remains to be clearly established. The gene discussed is PALLD; the disease is ovarian carcinoma.